ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

ClinicalTrials.gov ID: NCT06581432

Public ClinicalTrials.gov record NCT06581432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-mutated or Overexpressed/Amplified Solid Tumours

Study identification

NCT ID
NCT06581432
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
430 participants

Conditions and interventions

Conditions

Interventions

  • Zongertinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2024
Primary completion
Dec 30, 2027
Completion
Dec 28, 2028
Last update posted
Apr 16, 2026

2024 – 2028

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Alaska Oncology and Hematology, LLC Anchorage Alaska 99508 Recruiting
University of Arizona Comprehensive Cancer Center Tucson Arizona 85719 Not yet recruiting
Precision NextGen Oncology Beverly Hills California 90212 Recruiting
Scripps Cancer Center Torrey Pines La Jolla California 92037 Not yet recruiting
Valkyrie Clinical Trials Los Angeles California 90067 Recruiting
Yale University School of Medicine New Haven Connecticut 06511 Recruiting
BRCR Global Tamarac Florida 33321 Recruiting
Illinois Cancer Specialists Arlington Heights Illinois 60005 Not yet recruiting
Community MD Anderson Cancer Center - East Medical Oncology Indianapolis Indiana 46219 Recruiting
Maryland Oncology Hematology, Columbia Columbia Maryland 21044 Not yet recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Not yet recruiting
Icahn School of Medicine at Mount Sinai New York New York 10029 Recruiting
Memorial Sloan-Kettering Cancer Center New York New York 10065 Recruiting
Taylor Cancer Research Center Maumee Ohio 43537 Not yet recruiting
Alliance Cancer Specialists, PC, Wynnewood Wynnewood Pennsylvania 19096 Not yet recruiting
Sarah Cannon Research Institute at Mary Crowley Dallas Texas 75230 Not yet recruiting
The University of Texas MD Anderson Cancer Center Houston Texas 77030 Recruiting
Texas Oncology - Plano West Plano Texas 75093 Not yet recruiting
Virginia Cancer Specialists, PC Fairfax Virginia 22031 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06581432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06581432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →